Last reviewed · How we verify
Unstimulated saliva sampling
At a glance
| Generic name | Unstimulated saliva sampling |
|---|---|
| Also known as | Unstimulated saliva collection |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Periodontitis and Inflammation
- Kynurenine Pathway in Parkinson's Disease (NA)
- Free Amino-acid Composition of Peri-implant and Periodontal Conditions
- Hypoxia and Kynurenine Pathway in Periodontal Inflammation
- Evaluation of Nucleotide-Binding Oligomerization Domain-Containing Protein (NOD) 1 and NOD 2 (NA)
- EDN and Eosinophilic Esophagitis (NA)
- Effect of Systemic Retinoic Acid Use on Micro Ribonucleic Acid (mRNA) Expression (NA)
- Periodontitis and Inflammation: Study on Biological Samples
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Unstimulated saliva sampling CI brief — competitive landscape report
- Unstimulated saliva sampling updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI